查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1547943

全球照護端傳染病檢測市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Point of Care Infectious Disease Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

全球即時傳染病檢測市場需求預計將從 2023 年的 401.2 億美元增至 2032 年的近 810.1 億美元，2024-2032 年研究期間複合年成長率為 8.12%。

照護端傳染病檢測是一種檢測機制，用於在非常接近患者的環境中檢測主要病原體，從而更好地管理傳染病。它用於檢測多種主要疾病，如愛滋病毒、HPV、結核病、登革熱、伊波拉病毒、冠狀病毒。這種測試有助於遏止傳染病的快速爆發。它們通常用於資源有限的環境，及時獲得優質醫療服務是一項挑戰。 POCT 的一些例子包括側流免疫測定 (LFIA) 和酵素免疫測定 (ELISA)。只有建立有效的檢測結果報告和後續照護系統，POCT 才會對社會產生正面影響。

市場動態

全球傳染病的高發生率以及病毒和流行病的快速爆發是POCT市場成長的主要驅動力。低成本攜帶式設備的可用性、農村和偏遠地區的易用性、缺乏滿足貧困人口需求的醫療基礎設施將是推動該市場成長的主要因素。政府增加對這些測試方法的小型化和標準化的投資將是一個巨大的市場推動力。 COVID-19大流行期間ELISA試劑盒銷量的增加導致POCT市場以驚人的速度成長。阻礙該市場的主要問題是低抗原水平樣本缺乏臨床敏感性以及假陰性結果的可能性增加。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球照護端傳染病檢測市場的各個細分市場進行了包容性評估。照護端傳染病檢測產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

照護端傳染病檢測市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按疾病分類

  • 愛滋病毒POC
  • 艱難梭菌POC
  • 乙肝病毒POC
  • 肺炎或鏈球菌相關感染
  • 呼吸道合胞病毒 (RSV) POC
  • HPV POC
  • 流感/流感 POC
  • 丙型肝炎病毒POC
  • 耐甲氧西林金黃色葡萄球菌POC
  • 結核病和抗藥性結核病 POC
  • HSV（單純皰疹病毒）POC
  • 其他傳染病POC

按最終用途

  • 醫院
  • 診所
  • 家
  • 輔助生活醫療設施
  • 實驗室
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲即時傳染病檢測市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。即時傳染病檢測市場的主要參與者包括 Alere、Thermo Fisher Scientific Inc、F. Hoffmann-La Roche Ltd、Siemens Healthineers、BD & Company、Chembio Diagnostics Inc.、Trinity Biotech、Cardinal Health、Quest Diagnostics Inc.。 -Rad Labs Inc.、BioMeRieux SA、Sight Diagnostics Ltd.、Gene POC、Trivitron Healthcare、OJ-Bio Ltd.、Ortho-Clinical Diagnostics。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：照護端傳染病檢測 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按疾病分類的市場吸引力分析
    • 按最終用途分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球照護端傳染病檢測市場分析：依疾病分類

  • 按疾病分類概述
  • 歷史和預測數據
  • 按疾病分析
  • 愛滋病毒POC
  • 艱難梭菌POC
  • 乙肝病毒POC
  • 肺炎或鏈球菌相關感染
  • 呼吸道合胞病毒 (RSV) POC
  • HPV POC
  • 流感/流感 POC
  • 丙型肝炎病毒POC
  • 耐甲氧西林金黃色葡萄球菌POC
  • 結核病和抗藥性結核病 POC
  • HSV（單純皰疹病毒）POC
  • 其他傳染病POC

第 6 章：全球照護端傳染病檢測市場分析：依最終用途分類

  • 按最終用途分類的概述
  • 歷史和預測數據
  • 按最終用途分析
  • 醫院
  • 診所
  • 家
  • 輔助生活醫療設施
  • 實驗室
  • 其他

第 7 章：全球照護端傳染病檢測市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 8 章：照護端傳染病檢測公司的競爭格局

  • 照護端傳染病檢測市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 9 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Alere
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Thermo Fisher Scientific Inc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • F. Hoffmann-La Roche Ltd
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Siemens Healthineers
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • BD & Company
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Chembio Diagnostics Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Trinity Biotech
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Cardinal Health
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Quest Diagnostics Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Bio-Rad Labs Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • BioMeRieux SA
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Sight Diagnostics Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Gene POC
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Trivitron Healthcare
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • OJ-Bio Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Ortho-Clinical Diagnostics
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR11212341

The global demand for Point of Care Infectious Disease Testing Market is presumed to reach the market size of nearly USD 81.01 Billion by 2032 from USD 40.12 Billion in 2023 with a CAGR of 8.12% under the study period 2024-2032.

Point of Care Infectious Disease Testing is a testing mechanism used to test major pathogens in an environment setting very close to the patient and enable better management of infectious diseases. It is used to test several major diseases like HIV, HPV, TB, dengue, Ebola, Coronaviruses. This testing can help in the containment of rapid outbreaks of infectious diseases. They are commonly used in resource-limited settings where access to quality medical care in a timely manner is a challenge. Some examples of POCT are lateral flow immunoassays (LFIA) and enzyme immunoassay (ELISA). POCT will have a positive impact on society only if effective systems for reporting test results and follow up care are in place.

MARKET DYNAMICS

The high prevalence of infectious diseases and rapid outbreaks of viruses and epidemics globally are the main drivers for the growth of the POCT market. Availability of low-cost portable devices, ease of use in rural and remote areas, lack of healthcare infrastructure to meet the demands of the distressed will be major factors that will boost the growth of this market. Increased investments from governments for miniaturization and standardization of these testing methods will be a great market booster. Increase in the sales of ELISA kits during the COVID-19 pandemic led to the growth of the POCT market at an alarming rate. The major concerns hampering this market are lack of clinical sensitivity for specimens with low antigen levels and increased possibility of false-negative results.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Point of Care Infectious Disease Testing. The growth and trends of Point of Care Infectious Disease Testing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Point of Care Infectious Disease Testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Disease

  • HIV POC
  • Clostridium difficile POC
  • HBV POC
  • Pneumonia or Streptococcus associated infections
  • Respiratory syncytial virus (RSV) POC
  • HPV POC
  • Influenza/Flu POC
  • HCV POC
  • MRSA POC
  • TB and drug-resistant TB POC
  • HSV (Herpes Simplex Virus) POC
  • Other infectious disease POC

By End-Use

  • Hospitals
  • Clinics
  • Home
  • Assisted Living Healthcare Facilities
  • Laboratories
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Point of Care Infectious Disease Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Point of Care Infectious Disease Testing market include Alere, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Siemens Healthineers, BD & Company, Chembio Diagnostics Inc., Trinity Biotech, Cardinal Health, Quest Diagnostics Inc., Bio-Rad Labs Inc., BioMeRieux SA, Sight Diagnostics Ltd., Gene POC, Trivitron Healthcare, OJ-Bio Ltd., Ortho-Clinical Diagnostics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. POINT OF CARE INFECTIOUS DISEASE TESTING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Disease
    • 3.7.2 Market Attractiveness Analysis By End-Use
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET ANALYSIS BY DISEASE

  • 5.1. Overview By Disease
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Disease
  • 5.4. HIV POC Historic and Forecast Sales By Regions
  • 5.5. Clostridium difficile POC Historic and Forecast Sales By Regions
  • 5.6. HBV POC Historic and Forecast Sales By Regions
  • 5.7. Pneumonia or Streptococcus associated infections Historic and Forecast Sales By Regions
  • 5.8. Respiratory syncytial virus (RSV) POC Historic and Forecast Sales By Regions
  • 5.9. HPV POC Historic and Forecast Sales By Regions
  • 5.10. Influenza/Flu POC Historic and Forecast Sales By Regions
  • 5.11. HCV POC Historic and Forecast Sales By Regions
  • 5.12. MRSA POC Historic and Forecast Sales By Regions
  • 5.13. TB and drug-resistant TB POC Historic and Forecast Sales By Regions
  • 5.14. HSV (Herpes Simplex Virus) POC Historic and Forecast Sales By Regions
  • 5.15. Other infectious disease POC Historic and Forecast Sales By Regions

6. GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET ANALYSIS BY END-USE

  • 6.1. Overview By End-Use
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By End-Use
  • 6.4. Hospitals Historic and Forecast Sales By Regions
  • 6.5. Clinics Historic and Forecast Sales By Regions
  • 6.6. Home Historic and Forecast Sales By Regions
  • 6.7. Assisted Living Healthcare Facilities Historic and Forecast Sales By Regions
  • 6.8. Laboratories Historic and Forecast Sales By Regions
  • 6.9. Others Historic and Forecast Sales By Regions

7. GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE POINT OF CARE INFECTIOUS DISEASE TESTING COMPANIES

  • 8.1. Point of Care Infectious Disease Testing Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF POINT OF CARE INFECTIOUS DISEASE TESTING INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Alere
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Thermo Fisher Scientific Inc
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. F. Hoffmann-La Roche Ltd
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Siemens Healthineers
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. BD & Company
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. Chembio Diagnostics Inc.
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Trinity Biotech
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Cardinal Health
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Quest Diagnostics Inc.
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Bio-Rad Labs Inc.
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments
  • 9.13. BioMeRieux SA
    • 9.13.1 Company Overview
    • 9.13.2 Company Revenue
    • 9.13.3 Products
    • 9.13.4 Recent Developments
  • 9.14. Sight Diagnostics Ltd.
    • 9.14.1 Company Overview
    • 9.14.2 Company Revenue
    • 9.14.3 Products
    • 9.14.4 Recent Developments
  • 9.15. Gene POC
    • 9.15.1 Company Overview
    • 9.15.2 Company Revenue
    • 9.15.3 Products
    • 9.15.4 Recent Developments
  • 9.16. Trivitron Healthcare
    • 9.16.1 Company Overview
    • 9.16.2 Company Revenue
    • 9.16.3 Products
    • 9.16.4 Recent Developments
  • 9.17. OJ-Bio Ltd.
    • 9.17.1 Company Overview
    • 9.17.2 Company Revenue
    • 9.17.3 Products
    • 9.17.4 Recent Developments
  • 9.18. Ortho-Clinical Diagnostics
    • 9.18.1 Company Overview
    • 9.18.2 Company Revenue
    • 9.18.3 Products
    • 9.18.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Disease (USD MN)
  • HIV POC Market Sales By Geography (USD MN)
  • Clostridium difficile POC Market Sales By Geography (USD MN)
  • HBV POC Market Sales By Geography (USD MN)
  • Pneumonia or Streptococcus associated infections Market Sales By Geography (USD MN)
  • Respiratory syncytial virus (RSV) POC Market Sales By Geography (USD MN)
  • HPV POC Market Sales By Geography (USD MN)
  • Influenza/Flu POC Market Sales By Geography (USD MN)
  • HCV POC Market Sales By Geography (USD MN)
  • MRSA POC Market Sales By Geography (USD MN)
  • TB and drug-resistant TB POC Market Sales By Geography (USD MN)
  • HSV (Herpes Simplex Virus) POC Market Sales By Geography (USD MN)
  • Other infectious disease POC Market Sales By Geography (USD MN)
  • Analysis By End-Use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Clinics Market Sales By Geography (USD MN)
  • Home Market Sales By Geography (USD MN)
  • Assisted Living Healthcare Facilities Market Sales By Geography (USD MN)
  • Laboratories Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Point of Care Infectious Disease Testing Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Point of Care Infectious Disease Testing Report
  • Market Research Process
  • Market Research Methodology
  • Global Point of Care Infectious Disease Testing Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Disease
  • Market Attractiveness Analysis By End-Use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Disease (USD MN)
  • HIV POC Market Sales By Geography (USD MN)
  • Clostridium difficile POC Market Sales By Geography (USD MN)
  • HBV POC Market Sales By Geography (USD MN)
  • Pneumonia or Streptococcus associated infections Market Sales By Geography (USD MN)
  • Respiratory syncytial virus (RSV) POC Market Sales By Geography (USD MN)
  • HPV POC Market Sales By Geography (USD MN)
  • Influenza/Flu POC Market Sales By Geography (USD MN)
  • HCV POC Market Sales By Geography (USD MN)
  • MRSA POC Market Sales By Geography (USD MN)
  • TB and drug-resistant TB POC Market Sales By Geography (USD MN)
  • HSV (Herpes Simplex Virus) POC Market Sales By Geography (USD MN)
  • Other infectious disease POC Market Sales By Geography (USD MN)
  • Global Market Analysis By End-Use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Clinics Market Sales By Geography (USD MN)
  • Home Market Sales By Geography (USD MN)
  • Assisted Living Healthcare Facilities Market Sales By Geography (USD MN)
  • Laboratories Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.